LSN News › India

World · India Bureau

Kerala faces escalating antimicrobial resistance crisis, surveillance data reveals

Fresh data from Kerala's antimicrobial resistance surveillance network paints an alarming picture of drug-resistant infections spreading across hospitals and communities. Highly resistant pathogens now dominate intensive care units while common bacteria resistant to standard antibiotics are increasingly appearing in community-acquired infections.

LSN India · 20 September 2026

Kerala faces escalating antimicrobial resistance crisis, surveillance data reveals

Kerala is grappling with a deepening antimicrobial resistance (AMR) crisis, according to 2025 data released by the Kerala Antimicrobial Resistance Surveillance Network. The findings underscore the scale of the challenge facing the state's healthcare system, with drug-resistant bacteria now commonplace rather than exceptional in hospital settings.

The surveillance data documents resistance at multiple levels of infection severity. Intensive care units are confronting highly resistant pathogens that pose significant treatment challenges, while community-acquired infections—including antibiotic-resistant strains of Shigella—are becoming increasingly prevalent in the general population. The emergence of Shigella resistant to commonly prescribed antibiotics marks a particular concern for public health authorities.

The shift toward resistance as the norm represents a fundamental change in Kerala's infection landscape. Hospital-acquired and community-based bacterial infections that once responded readily to standard antibiotic regimens are now frequently demonstrating multi-drug resistance patterns. This development has significant implications for treatment protocols, infection control measures, and healthcare resource allocation across the state.

The surveillance network's findings suggest that Kerala faces mounting pressure to implement comprehensive strategies addressing antimicrobial stewardship, infection prevention, and rational antibiotic use. The data underscores the urgency of coordinated action among healthcare facilities, public health agencies, and medical professionals to combat the progressive spread of resistant pathogens.